Evidence map›Paper›PMID 27764769›Full record

ArticlePhysiological genomics2016

Establishing the involvement of the novel gene AGBL5 in retinitis pigmentosa by whole genome sequencing.

Kari Branham, Hiroko Matsui, Pooja Biswas, Aditya A Guru, Michael Hicks, John J Suk, He Li, David Jakubosky, Tao Long, Amalio Telenti and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Physiological genomics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Kari BranhamKellogg Eye Center, University of Michigan, Ann Arbor, Michigan.
Hiroko MatsuiInstitute for Genomic Medicine, University of California San Diego, La Jolla, California.
Pooja BiswasShiley Eye Institute, University of California San Diego, La Jolla, California.ORCID 0000-0002-8545-9296
Aditya A GuruShiley Eye Institute, University of California San Diego, La Jolla, California.
Michael HicksHuman Longevity Incorporated, San Diego, California.
John J SukShiley Eye Institute, University of California San Diego, La Jolla, California.
He LiInstitute for Genomic Medicine, University of California San Diego, La Jolla, California.
David JakuboskyInstitute for Genomic Medicine, University of California San Diego, La Jolla, California.
Tao LongHuman Longevity Incorporated, San Diego, California.
Amalio TelentiHuman Longevity Incorporated, San Diego, California.
Naoki NariaiInstitute for Genomic Medicine, University of California San Diego, La Jolla, California.
John R HeckenlivelyKellogg Eye Center, University of Michigan, Ann Arbor, Michigan.
Kelly A FrazerInstitute for Genomic Medicine, University of California San Diego, La Jolla, California.
Paul A SievingNational Eye Institute, National Institutes of Health, Bethesda, Maryland.
Radha AyyagariShiley Eye Institute, University of California San Diego, La Jolla, California; rayyagari@ucsd.edu.
University of California San Diego · USHuman Longevity (United States) · USW.K. Kellogg Foundation · USNational Institutes of Health · US

Funding

Vision BiostatisticsP30EY022589 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LINDA M ZANGWILL · 2012 to 2026
$10.3M
Molecular Basis of Hereditary Retinal DegenerationsR01EY021237 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AYYAGARI, RADHA · 2011 to 2020
$5.6M
NEI NIH HHS P30 EY022589NEI NIH HHS R01 EY021237
6 · The paper itself

Abstract

While more than 250 genes are known to cause inherited retinal degenerations (IRD), nearly 40-50% of families have the genetic basis for their disease unknown. In this study we sought to identify the underlying cause of IRD in a family by whole genome sequence (WGS) analysis. Clinical characterization including standard ophthalmic examination, fundus photography, visual field testing, electroretinography, and review of medical and family history was performed. WGS was performed on affected and unaffected family members using Illumina HiSeq X10. Sequence reads were aligned to hg19 using BWA-MEM and variant calling was performed with Genome Analysis Toolkit. The called variants were annotated with SnpEff v4.11, PolyPhen v2.2.2, and CADD v1.3. Copy number variations were called using Genome STRiP (svtoolkit 2.00.1611) and SpeedSeq software. Variants were filtered to detect rare potentially deleterious variants segregating with disease. Candidate variants were validated by dideoxy sequencing. Clinical evaluation revealed typical adolescent-onset recessive retinitis pigmentosa (arRP) in affected members. WGS identified about 4 million variants in each individual. Two rare and potentially deleterious compound heterozygous variants p.Arg281Cys and p.Arg487* were identified in the gene ATP/GTP binding protein like 5 (AGBL5) as likely causal variants. No additional variants in IRD genes that segregated with disease were identified. Mutation analysis confirmed the segregation of these variants with the IRD in the pedigree. Homology models indicated destabilization of AGBL5 due to the p.Arg281Cys change. Our findings establish the involvement of mutations in AGBL5 in RP and validate the WGS variant filtering pipeline we designed.

Indexed as

AdolescentCarboxypeptidasesDNA Mutational AnalysisElectroretinographyFemaleGenetic Association StudiesHumansMaleMutationPedigreeRetinal DegenerationRetinitis PigmentosaWhole Genome SequencingYoung AdultAGBL5 protein, humanCarboxypeptidasesophthalmologywhole genome sequencing

Identifiers

PMID27764769
PMCPMC5206392
OpenAlexW2528893066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.